Role of Intestinal Microbiota in Ulcerative Colitis
Role of Intestinal Microbiota in Ulcerative Colitis Role of Intestinal Microbiota in Ulcerative Colitis
List of Centents Methodology appendixes ......................................................................................................... 149 Appendix 1 ............................................................................................................................... 151 Appendix 2 ............................................................................................................................... 153 Appendix 3 ............................................................................................................................... 154 Discussion and conclusion ........................................................................................................ 157 7. Discussion and perspectives .............................................................................................. 159 7.1. Compositional changes of the fecal microbiota and their capacity to colonize mucus .. 159 7.2. Modulation of the fecal microbial community from UC patients ................................... 162 7.3. Validation of prebiotic properties of novel carbohydrates ............................................. 164 8. Conclusion ......................................................................................................................... 166 References ............................................................................................................................... 167 XVI
Theoretical part
- Page 1: Role of Intestinal Microbiota in Ul
- Page 4 and 5: Role of Intestinal Microbiota in Ul
- Page 6 and 7: Preface Preface This thesis present
- Page 8 and 9: Summary Summary The microbiota of t
- Page 10 and 11: Dansk sammendrag Dansk sammendrag M
- Page 12 and 13: Introduction and objectives Introdu
- Page 14 and 15: List of Manuscripts Not included in
- Page 16 and 17: List of contents List of Centents P
- Page 21 and 22: 1. The intestinal environment Theor
- Page 23 and 24: Theoretical part 5 1. The intestina
- Page 25 and 26: 2. The colonic environment Theoreti
- Page 27 and 28: Theoretical part 9 2. The colonic e
- Page 29 and 30: Table 1: The presence of glycoside
- Page 31 and 32: Theoretical part Figure 3: The colo
- Page 33 and 34: 3. Inflammatory Bowel disease Theor
- Page 35 and 36: Theoretical part 17 3. Inflammatory
- Page 37 and 38: Theoretical part 19 4. Modulation o
- Page 39 and 40: Theoretical part 21 4. Modulation o
- Page 41 and 42: Theoretical part 23 4. Modulation o
- Page 43 and 44: Table 4: Clinical trials on the pre
- Page 45 and 46: Theoretical part 5. Production of p
- Page 47 and 48: Theoretical part 5. Production of p
- Page 49 and 50: Theoretical part 5. Production of p
- Page 51: Methodology part
- Page 54 and 55: Methodology part 6. Methodology, co
- Page 56 and 57: Methodology part 6. Methodology, co
- Page 58 and 59: Methodology part 6. Methodology, co
- Page 60 and 61: Introduction Methodology part 42 Pa
- Page 62 and 63: Abstract Background Detailed knowle
- Page 64 and 65: depending the level of disease acti
- Page 66 and 67: in 1 x TAE at 60 °C for 16 h at 36
List <strong>of</strong> Centents<br />
Methodology appendixes ......................................................................................................... 149<br />
Appendix 1 ............................................................................................................................... 151<br />
Appendix 2 ............................................................................................................................... 153<br />
Appendix 3 ............................................................................................................................... 154<br />
Discussion and conclusion ........................................................................................................ 157<br />
7. Discussion and perspectives .............................................................................................. 159<br />
7.1. Compositional changes <strong>of</strong> the fecal microbiota and their capacity to colonize mucus .. 159<br />
7.2. Modulation <strong>of</strong> the fecal microbial community from UC patients ................................... 162<br />
7.3. Validation <strong>of</strong> prebiotic properties <strong>of</strong> novel carbohydrates ............................................. 164<br />
8. Conclusion ......................................................................................................................... 166<br />
References ............................................................................................................................... 167<br />
XVI
Change language